Harrow Health Inc

NASDAQ:HROW  
9.39
-0.34 (-3.49%)
Mergers / Acquisitions

Visionology Acquires Exclusive Worldwide License To Sparcs Contrast Sensitivity Testing Technology

Published: 06/03/2021 12:24 GMT
Harrow Health Inc (HROW) - Visionology Acquires Exclusive Worldwide License to Sparcs Contrast Sensitivity Testing Technology.